From: Encapsulation and assessment of therapeutic cargo in engineered exosomes: a systematic review
Drug types | Drugs | Disease types | In vitro | In vivo | References |
---|---|---|---|---|---|
RNAs | miR-145-5p | Pancreatic ductal adenocarcinoma | Cancer cell proliferation and invasion↓ | Cancerous cells apoptosis↑ | [27] |
miR-183-5p | Breast cancer | Growth and metastasis of cancer cells↓ | Tumor growth↓ | [28] | |
miR-1827 | Colorectal | Cancer cell proliferation, migration, and invasion↓ | Tumor growth and liver metastasis↓ | [29] | |
Cas9 mRNA | Breast cancer | Cancer cell growth↓ | Tumor growth↓ | [30] | |
piRNA-18 | Colon cancer | Cancer cell proliferation↓ | Tumor proliferation, migration, and invasion↓ | [31] | |
circABCB10 | Colorectal | Cancer cell growth↓ | Tumor growth↓ | [32] | |
Proteins | CIITA | Lymphoma | T cell response↑ | T cell response↑ | [33] |
NF-κB | Prostate cancer | Androgen receptor inhibition↑ | Tumor growth↓ | [34] | |
TRAIL | Lymphoma | Leukocyte apoptosis↑ | No effect on tumor growth | [35] | |
Compounds | Paclitaxel | Breast cancer | T cell ↑ | Tumor growth↓ | [36] |
Doxorubicin | Triple-negative breast cancer | Cancer cell growth↓ | Tumor growth↓ | [37] | |
Curcumin | Glioblastoma | Glioblastoma cell growth↓ | – | [38] |